Renaissance Technologies - SKYSTAR BIO-PHARMA CO ownership

SKYSTAR BIO-PHARMA CO's ticker is SKBI and the CUSIP is 830884300. A total of 1 filers reported holding SKYSTAR BIO-PHARMA CO in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SKYSTAR BIO-PHARMA CO
ValueSharesWeighting
Q3 2015$50,000
-55.8%
52,300
+23.5%
0.00%
Q2 2015$113,000
+82.3%
42,358
+168.1%
0.00%
Q1 2015$62,000
+21.6%
15,800
+31.0%
0.00%
Q4 2014$51,000
-16.4%
12,059
-17.4%
0.00%
Q3 2014$61,00014,6000.00%
Other shareholders
SKYSTAR BIO-PHARMA CO shareholders Q4 2015
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 147,926$141,0000.01%
Tower Research Capital LLC (TRC) 181$00.00%
HighTower Advisors, LLC 22,845$22,0000.00%
MORGAN STANLEY 11,593$11,0000.00%
BlackRock Institutional Trust Company, N.A. 175,708$167,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 15,900$15,0000.00%
Walleye Trading LLC 200$00.00%
Citadel Advisors 18,296$17,0000.00%
Renaissance Technologies 52,300$50,0000.00%
UBS Group AG 3,304$3,0000.00%
View complete list of SKYSTAR BIO-PHARMA CO shareholders